Skip to main content

Want a detailed portfolio tracker?

Compugen (CGEN) P/E (2009 - 2026)

Compugen (CGEN) P/E from Dec 31, 2009 to Jul 21, 2026. The TTM Compugen (CGEN) P/E is 6.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Compugen (CGEN)

YearP/EChange
20266.66+62.75%
20254.09-142.52%
2024-9.63+89.11%
2023-5.09+181.46%
2022-1.81-83.36%
2021-10.87-68.15%
2020-34.12+145.94%
2019-13.87+362.02%
2018-3.00-25.99%
2017-4.06-68.29%
2016-12.79-20.19%
2015-16.03-57.53%
2014-37.75+44.83%
2013-26.06+97.33%
2012-13.21-43.35%
2011-23.32+0.61%
2010-23.18-44.32%
2009-41.62N/A

Comparison Compugen (CGEN) P/E with competitors

Compugen (CGEN) P/E is 6.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.97%
NBYStablecoin Development Corp0.00-99.94%
ENLVEnlivex Ltd0.07-98.88%
FGENFibroGen Inc0.24-96.40%
CHRSCoherus Biosciences Inc0.85-87.26%
FBIOFortress Biotech Inc0.95-85.76%
ORMPOramed Pharmaceuticals Inc1.50-77.44%
AGENAgenus Inc3.01-54.83%
INVAInnoviva Inc3.15-52.66%
VXRTVaxart Inc3.55-46.72%
CRMDCorMedix Inc3.63-45.54%
CVACCureVac N.V.4.45-33.27%
GLPGGalapagos NV4.86-27.07%
SRPTSarepta Therapeutics Inc4.88-26.72%
ABEOAbeona Therapeutics Inc5.39-19.13%
ABUSArbutus Biopharma Corp5.60-16.01%
ZVRAZevra Therapeutics Inc5.89-11.63%
SPROSpero Therapeutics Inc6.23-6.51%
RIGLRigel Pharmaceuticals6.87+3.15%
SLXNSilexion Therapeutics Corp7.30+9.51%
OMEROmeros Corporation9.26+38.97%
AUPHAurinia Pharmaceuticals Inc9.58+43.87%
PLXProtalix BioTherapeutics Inc10.89+63.47%
ACADAcadia Pharmaceuticals Inc11.73+76.04%
TBPHTheravance Biopharma Inc12.26+84.05%
ADMAAdma Biologics Inc12.42+86.39%
HRMYHarmony Biosciences Holdings Inc13.82+107.44%
SABSSAB Biotherapeutics Inc14.14+112.18%
NAGENiagen Bioscience Inc14.82+122.42%
INCYIncyte Corp15.82+137.49%
REGNRegeneron Pharmaceuticals Inc15.86+138.01%
PBYIPuma Biotechnology Inc17.32+159.91%
CPRXCatalyst Pharmaceuticals Inc17.44+161.76%
EXELExelixis Inc17.54+163.24%
TGTXTG Therapeutics Inc18.97+184.68%
MDXGMimedx Group Inc20.55+208.49%
XOMAXOMA Royalty Corp22.87+243.35%
ARGXArgen X SE24.30+264.72%
CTMXCytomX Therapeutics Inc24.82+272.57%
XOMAOXOMA Royalty Corp25.34+280.43%
HALOHalozyme Therapeutics Inc25.62+284.62%
XOMAPXOMA Royalty Corp25.67+285.31%
VRTXVertex Pharmaceuticals Inc27.99+320.21%
RPRXRoyalty Pharma plc - Class A28.69+330.61%
SLNOSoleno Therapeutics Inc29.02+335.53%
ASNDAscendis Pharma A/S30.09+351.59%
LGNDLigand Pharmaceuticals Inc - Class B37.91+469.07%
APLSApellis Pharmaceuticals Inc39.02+485.72%
BMRNBiomarin Pharmaceutical Inc42.21+533.61%
KRYSKrystal Biotech Inc45.34+580.62%
ONCBeiGene Ltd69.54+943.82%
PHARPharming Group N.V.75.03+1026.15%
TECHBio-Techne Corp101.96+1430.42%
VCELVericel Corp109.92+1549.95%
ALNYAlnylam Pharmaceuticals Inc117.96+1670.68%
GMABGenmab140.29+2005.80%
TLXTelix Pharmaceuticals Ltd162.15+2333.95%
CORTCorcept Therapeutics Inc212.86+3095.04%